The analysis of the entire HLA, partial non-HLA and HPV for Chinese women with cervical cancer

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1808-1813

  Wu, Yuping ^a   Zhang, Qinming ^b   Liu, Benrong ^a   Yu, Guifang ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Gansu Cancer Hospital   (China)

^c ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

Author keywords

Cervical cancer; HLA; HPV; Microsatellite marker; Polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CHINA; CHROMOSOME 16Q; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HLA SYSTEM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; MOLECULAR INTERACTION; NONHUMAN; PREVALENCE; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; ALLELES; ALPHAPAPILLOMAVIRUS; ANTIGEN PRESENTATION; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HLA-DP ANTIGENS; HOMOZYGOTE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 50849121439     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21251     Document Type: Article

References (27)

1. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. 1994. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 6:157-162.
2. Arias-Pulido H, Joste N, Wheeler CM. 2004. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype. Genes Chromosomes Cancer 40:277-284.
3. Carreon JD, Martin MP, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Zaino RJ, Carrington M, Wang SS. 2005. Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. Tissue Antigens 66:321-324.
4. Chan DP, Cheung TH, Tam AO, Cheung JL, Yim SF, Lo KW, Siu NS, Zhou DX, Chan PK. 2005. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis 192:1749-1756.
5. Chan PK, Cheung JL, Cheung TH, Lin CK, Tam AO, Chan DP, Zhou DX, Lo KW, Yim SF, Siu SS. 2006. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer 118:1430-1435.
6. Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, Cheung JL, Tam AO, Tang JW. 2007. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. J Med Virol 79:970-976.
7. Dean J, Dean A, Burton J. 1990. Public domain software for epidemiology and disease surveillance. WHO AIDS Series.
8. Engelmark M, Beskow A, Magnusson J, Erlich H, Gyllensten U. 2004. Affected sibpair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum Mol Genet 13:1951-1958.
9. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. 2000. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 9:1183-1191.
10. Marsh SG. 2004. Nomenclature for factors of the HLA system, update May 2004. Hum Immunol 65:1546-1547.
11. Munoz N, Bosch FX. 1996. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Organ 30:362-377.
12. Panotopoulou E, Tserkezoglou A, Kouvousi M, Tsiaousi I, Chatzieleftheriou G, Daskalopoulou D, Magiakos G. 2007. Prevalence of human papillomavirus types 6, 11 16, 18 31, and 33 in a cohort of Greek women. J Med Virol 79:1898-1905.
13. Parkin DM, Pisani P, Ferlay J. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841.
14. Sanjeevi CB, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, Dillner J, Lernmark A. 1996. Different HLA DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 68:409-414.
15. Shiina T, Inoko H, Kulski JK. 2004. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64:631-649.
16. Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, Coggill P, Dunham I, Forbes S, Halls K, Howson JM, Humphray SJ, Hunt S, Mungall AJ, Osoegawa K, Palmer S, Roberts AN, Rogers J, Sims S, Wang Y, Wilming LG, Elliott JF, de Jong PJ, Sawcer S, Todd JA, Trowsdale J, Beck S. 2004. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 14:1176-1187.
17. Svejgaard A, Ryder LP. 1994. HLA and disease associations: Detecting the strongest association. Tissue Antigens 43:18-27.
18. The MHC Sequencing Consortium. 1999. Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921-923.
19. Tsujimura A, Ota M, Katsuyama Y, Sada M, Miura H, Matsumiya K, Gotoh R, Nakatani T, Okuyama A, Takahara S. 2002. Susceptibility gene for nonobstructive azoospermia located near HLA-DR and -DQ loci in the HLA class II region. Hum Genet 110:192-197.
20. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
21. Wank R, Thomssen C. 1991. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352:723-725.
22. Wu Y, Chen Y, Li L, Yu G, He Y, Zhang Y. 2006a. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 87:1181-1188.
23. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006b. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264-269.
24. Wu Y, Chen Y, Li L, Cao Y, Liu Z, Liu B, Du Z, Zhang Y, Chen S, Lin Z, Xu A. 2006c. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer 118:3006-3011.
25. Wu Y, Liu B, Lin W, Xu Y, Li L, Zhang Y, Chen S, Xu A. 2007. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer. J Med Virol 79:439-446.
26. Xiang YB, Gao YT, Wang TJ. 1992. Application and comparison of Meta and pooled analysis in the study of cancer epidemiology. Chin J Oncol 21:354-358.
27. Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, de Vries EG, te Meerman GJ, van der Zee AG. 2005. Analysis of the entire HLA region in susceptibility for cervical cancer: A comprehensive study. J Med Genet 42:e49.